XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
The Company - Additional Information (Detail)
3 Months Ended
Mar. 31, 2018
Segment
Organization, Consolidation and Presentation of Financial Statements [Line Items]  
Number of operating segments 1
Rhopressa  
Organization, Consolidation and Presentation of Financial Statements [Line Items]  
Percentage of dosage designed to lower intraocular pressure 0.02%
Latanoprost  
Organization, Consolidation and Presentation of Financial Statements [Line Items]  
Percentage of dosage designed to lower intraocular pressure 0.005%